![James Porter](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Porter
Verkställande Direktör på
NUVALENT, INC.
Förmögenhet: 36 M $ per 2026-05-31
Profil
James R.
Porter is President, Chief Executive Officer & Director at Nuvalent, Inc. since 2020, with employment at the company starting in 2017.
Formerly, Dr. Porter was Vice President-Product Development at Infinity Pharmaceuticals, Inc. from 2002 to 2016.
Education includes a doctorate from Boston College.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
NUVALENT, INC. CLASS A 0,44 % | 2026-06-08 | 324 879 ( 0,44 % ) | 36 M $ | 2026-05-31 |
Aktiva positioner av James Porter
| Företag | Position | Start |
|---|---|---|
| NUVALENT, INC. | Verkställande Direktör | 2017-01-01 |
Tidigare kända positioner av James Porter
| Företag | Position | Slut |
|---|---|---|
| INFINITY PHARMACEUTICALS, INC. | Företagsledare/Principal | 2016-12-01 |
James Porters utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
44
Första gradens relationer
4
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
College of the Holy Cross (Massachusetts)
 College of the Holy Cross (Massachusetts) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Infinity Pharmaceuticals, Inc.
 Infinity Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops medicines for the treatment of cancer | Health Technology |
Boston College
 Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nuvalent, Inc.
 Nuvalent, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of targeted therapies for patients with cancer | Health Technology |
